Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,529 | 96 | 99.6% |
| Education | $6.02 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $240.55 | 19 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $132.82 | 9 | $0 (2017) |
| Allergan, Inc. | $131.04 | 8 | $0 (2020) |
| ABBVIE INC. | $128.57 | 6 | $0 (2023) |
| Amgen Inc. | $118.18 | 6 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $116.52 | 8 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $105.98 | 6 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $75.69 | 5 | $0 (2020) |
| Novo Nordisk Inc | $65.89 | 4 | $0 (2017) |
| PFIZER INC. | $58.90 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $49.38 | 2 | ABBVIE INC. ($49.38) |
| 2021 | $48.30 | 2 | AbbVie Inc. ($48.30) |
| 2020 | $45.77 | 2 | Allergan, Inc. ($26.25) |
| 2017 | $1,392 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($240.55) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: IMMUNOLOGY | ||||||
| 03/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/27/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/27/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Endocrinology | ||||||
| 09/18/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2017 | Ironwood Pharmaceuticals, Inc | ZURAMPIC (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Rheumatology | ||||||
| 09/11/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2017 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $6.02 | General |
| 09/08/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: DIABETES | ||||||
| 09/07/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/22/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Endocrinology | ||||||
| 08/11/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Endocrinology | ||||||
| 08/10/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/28/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 713 | 1,019 | $250,024 | $89,226 |
| 2022 | 12 | 730 | 1,015 | $257,586 | $92,203 |
| 2021 | 12 | 741 | 908 | $214,111 | $75,809 |
| 2020 | 14 | 829 | 992 | $210,561 | $69,204 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 481 | $128,908 | $45,706 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 162 | 162 | $64,800 | $22,196 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 112 | $20,384 | $6,759 | 33.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $6,320 | $4,488 | 71.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 20 | $10,820 | $3,469 | 32.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 46 | $6,026 | $3,302 | 54.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 48 | $2,448 | $1,560 | 63.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 97 | 104 | $9,360 | $1,149 | 12.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $867.00 | $552.50 | 63.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 13 | $91.00 | $44.33 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 427 | $114,436 | $41,655 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $63,200 | $22,412 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 124 | $22,568 | $8,502 | 37.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 24 | 30 | $22,020 | $7,062 | 32.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $9,600 | $2,927 | 30.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 40 | $5,069 | $2,732 | 53.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,928 | $1,460 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $2,142 | $1,345 | 62.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 23 | 29 | $4,089 | $1,292 | 31.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 14 | $1,998 | $1,215 | 60.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 102 | 108 | $9,720 | $1,085 | 11.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $816.00 | $516.70 | 63.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 273 | $73,164 | $26,897 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 147 | 147 | $58,800 | $21,331 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 159 | $28,938 | $9,898 | 34.2% |
About Dr. Georgia Kelley, M.D
Dr. Georgia Kelley, M.D is a Internal Medicine healthcare provider based in North Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013945211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Georgia Kelley, M.D has received a total of $1,535 in payments from pharmaceutical and medical device companies, with $49.38 received in 2023. These payments were reported across 97 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,529).
As a Medicare-enrolled provider, Kelley has provided services to 3,013 Medicare beneficiaries, totaling 3,934 services with total Medicare billing of $326,442. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location North Haven, CT
- Active Since 06/28/2006
- Last Updated 09/11/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1013945211
Products in Payments
- JARDIANCE (Drug) $131.92
- Prolia (Biological) $118.18
- ENTRESTO (Drug) $105.98
- UBRELVY (Drug) $97.93
- FARXIGA (Drug) $84.38
- XARELTO (Drug) $84.02
- VRAYLAR (Drug) $80.20
- STIOLTO (Drug) $54.26
- JANUVIA (Drug) $48.68
- Trintellix (Drug) $47.65
- VIAGRA (Drug) $46.58
- INVOKANA (Drug) $42.78
- ZURAMPIC (Drug) $41.88
- TOUJEO (Drug) $41.87
- SPIRIVA (Drug) $37.73
- Myrbetriq (Drug) $37.67
- Victoza (Drug) $34.87
- Edarbi (Drug) $33.08
- ADVAIR (Drug) $33.04
- SPIRIVA RESPIMAT (Drug) $31.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Haven
Dr. Lorenzo Galante, Md, MD
Internal Medicine — Payments: $30,892
Dr. Gidon Goldenberg, M.d, M.D
Internal Medicine — Payments: $6,274
Bjorn Ringstad, Md, MD
Internal Medicine — Payments: $4,225
Eric Liben, Md, MD
Internal Medicine — Payments: $3,652
Fausto Petruzziello, Md, MD
Internal Medicine — Payments: $3,443
Dr. Dianne Defusco, Md, MD
Internal Medicine — Payments: $2,258